These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2945420)

  • 21. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M; Sakai K
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
    Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
    Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
    Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nicorandil on kinetics of oxygen uptake at the onset of exercise in patients with coronary artery disease.
    Koike A; Hiroe M; Yajima T; Adachi H; Shimizu N; Kano H; Sugimoto K; Miyahara Y; Korenaga M; Marumo F
    Am J Cardiol; 1995 Sep; 76(7):449-52. PubMed ID: 7653442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved efficacy of high-dose versus medium- and low-dose diltiazem therapy for chronic stable angina pectoris.
    Go M; Hollenberg M
    Am J Cardiol; 1984 Mar; 53(6):669-73. PubMed ID: 6702613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.
    Rajaratnam R; Brieger DB; Hawkins R; Freedman SB
    Am J Cardiol; 1999 Apr; 83(7):1120-4, A9. PubMed ID: 10190531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris.
    Rice KR; Gervino E; Jarisch WR; Stone PH
    Am J Cardiol; 1990 May; 65(16):1097-101. PubMed ID: 2184649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
    Umezawa S; Ogawara S; Okamoto Y; Igawa M; Aonuma K; Inada M; Korenaga M; Hiroe M; Marumo F
    J Cardiol; 1996 Nov; 28(5):257-66. PubMed ID: 8953399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
    Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 34. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
    Thadani U; Parker JO
    Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of vasospastic angina--role of nicorandil.
    Kaski JC
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of nicorandil in congestive heart failure.
    Galié N; Varani E; Maiello L; Boriani G; Boschi S; Binetti G; Magnani B
    Am J Cardiol; 1990 Feb; 65(5):343-8. PubMed ID: 2137279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
    Di Pasquale G; Lusa AM; Manini GL; Dominici P; Coluccini M; Bassein L; Pinelli G
    G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.